Randomized phase II study to determine the optimal dose of 3-week cycle nab-paclitaxel in patients with metastatic breast cancer

BACKGROUND: Chemotherapy-induced peripheral neuropathy is commonly observed in patients treated with nanoparticle albumin–bound paclitaxel (nab-PTX). We conducted a multicenter randomized controlled study to evaluate the optimal dose of nab-PTX. METHODS: We compared three different doses of q3w nab-...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast
Autori principali: Tsurutani, Junji, Hara, Fumikata, Kitada, Masahiro, Takahashi, Masato, Kikawa, Yuichiro, Kato, Hiroaki, Sakata, Eiko, Naito, Yoichi, Hasegawa, Yoshie, Saito, Tsuyoshi, Iwasa, Tsutomu, Taira, Naruto, Takashima, Tsutomu, Kashiwabara, Kosuke, Aihara, Tomohiko, Mukai, Hirofumi
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7753189/
https://ncbi.nlm.nih.gov/pubmed/33341707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.breast.2020.12.002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi